We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





CTK Biotech’s Single-Use COVID-19 Antigen Self-Test Receives CE Mark

By LabMedica International staff writers
Posted on 04 Nov 2021
Print article
Image: OnSite COVID-19 Ag Self Test (Photo courtesy of CTK Biotech, Inc.)
Image: OnSite COVID-19 Ag Self Test (Photo courtesy of CTK Biotech, Inc.)

CTK Biotech, Inc. (Poway, CA, USA) has obtained the CE mark for its OnSite COVID-19 Ag Self Test and will begin shipping the new test to the countries that accept the CE mark this month.

The OnSite COVID-19 Ag Self Test is a single-use lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swab specimens from individuals suspected of COVID-19. The test is designed for use with self-collected samples within the first seven days post-onset of symptoms, as an aid in identifying SARS-CoV-2 infection. The easy-to-use test screens for COVID-19 in 15 to 20 minutes and uses nasal swab for ease of use and minimizing discomfort. The OnSite COVID-19 Ag Self-Test comes with two individually sealed test kits.

With over 20 years in infectious disease diagnostics, CTK has manufactured a line-up of professional use COVID-19 diagnostic tools. In addition to the OnSite COVID-19 Ag Self Test, the company also offers the OnSite COVID-19 Ag Rapid Test that detects the presence of antigens from the SARS-CoV-2 virus, namely the viral Nucleocapsid Protein (NP). The OnSite COVID-19 Ag Rapid Test can detect the NP mutants with mutations from the UK, South Africa, and Brazil variants.

In August this year, the company had launched the Aridia COVID-19 Real-Time PCR Test for the specific and qualitative detection of the novel coronavirus SARS-CoV-2, responsible for COVID-19, in respiratory specimens. The test targets the conserved regions of the SARS-CoV-2 ORF1ab and N genes using specific primers and fluorescently labeled probes. The test can detect the SARS-CoV-2 UK, South Africa, Brazil, California, Nigeria, and India (Delta) variants. Furthermore, as the Aridia COVID-19 Real-Time PCR Test detects two SARS-CoV-2 targets, its performance is less susceptible to the effects of variants than tests designed to detect a single target.

Related Links:
CTK Biotech, Inc. 

Gold Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Automated Blood Typing System
IH-500 NEXT
New
Histamine ELISA
Histamine ELISA
New
Tabletop Centrifuge
Mikro 185

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.